The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Trial
Comments
-
-
-
Mass General Hospital.pamstayner said:Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
Mass General Hospital.
-
Trialpamstayner said:Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
I think this is the one. Mine has spread to my lungs.
https://www.clinicaltrials.gov/ct2/show/NCT02659059?term=NCT02659059&rank=1
-
TrialEd Brabant said:Trial
I think this is the one. Mine has spread to my lungs.
https://www.clinicaltrials.gov/ct2/show/NCT02659059?term=NCT02659059&rank=1
Just requested the number from Mass General. Bit of a hiccup. Biopsy tissue sample is too small. Waiting for a plan of action. Might be able to use the tissue from 2011 when I had my right kidney removed. Hope to hear by Thursday.
-
Trial InfoEd Brabant said:Trial
Just requested the number from Mass General. Bit of a hiccup. Biopsy tissue sample is too small. Waiting for a plan of action. Might be able to use the tissue from 2011 when I had my right kidney removed. Hope to hear by Thursday.
16-217:
Protocol Title: A Phase I/II, Dose-Escalation and Cohort Expansion Study of the
Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered
in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
(cdx1127-02)
Sponsor Protocol Number: CDX1127-02
-
Trial Infopamstayner said:Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
16-217:
Protocol Title: A Phase I/II, Dose-Escalation and Cohort Expansion Study of the
Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered
in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
(cdx1127-02)
Sponsor Protocol Number: CDX1127-02
-
Trial #pamstayner said:Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
Here is the trial.
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 456 Bladder Cancer
- 312 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 408 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 803 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards